# Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers

> **NCT04452773** · NA · UNKNOWN · sponsor: **Reig Jofre Group** · enrollment: 315 (estimated)

## Conditions studied

- COVID19

## Interventions

- **DIETARY_SUPPLEMENT:** Manremyc
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04452773
- **Lead sponsor:** Reig Jofre Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-14
- **Primary completion:** 2020-09
- **Final completion:** 2021-12
- **Target enrollment:** 315 (ESTIMATED)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452773, "Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04452773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*